ASH 2011 Multiple Myeloma Update – Day Two The Myeloma Beacon Nearly 70 percent of the participants successfully collected enough stem cells and underwent a stem cell transplant in addition to the T-BiRD regimen. However, 31 percent of the trial participants halted T-BiRD treatment due to side effects. ... |
